EOLS · Evolus Inc
United States · RS rating 83 · As of 2026-11-03
| Price | 7.37 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 53 / 89 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 46 / 60 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +100.0% |
| Sales growth Q/Q | +30.9% |
| Distance from 52-week high | +20.8% |
| Market cap (USD) | $345.5M |